A first-of-its-kind AEX Buffer Screening Kit that can help you find the ideal buffer to optimize the separation of empty and full capsids while maintaining high yields. It can save months in your AAV2 process development at the polishing step.

ResolveOME is a unified, single-cell workflow that amplifies both the whole genome and full-length transcriptome and is adaptable to target protein detection, without any need to split samples or cross-reference data. Every tumor sample contains a macromolecular galaxy of information. Discover what you have been missing with BioSkryb Genomics.

Explore how Lonza leverages a standardized, systematic approach to tech transfers, manufacturing and pre-licensing inspection readiness to reliably take your therapy to commercialization.

An introduction to PBS Biotech including an explanation of our unique technology, overview of products and services, and statements from our executive team.

With years of experience and a team of highly trained experts, Cyagen can accelerate your research goals with all our cutting-edge biotechnological CRO services! From custom animal and cell line models, to iPSCs, cell and gene therapy, CAR-T/-NK, AI-AAV viral packaging, and evaluation services — we've got you covered.

Millipore CTDMO Services - Your cell and gene therapy needs a dedicated manufacturing partner with the scale, capacity, and commercial experience to manufacture high-quality gene therapies.

Label-Free High-Quality Kinetics and Quantitation in Real-Time - For over fifteen years, the industry-proven Octet®️ BLI platform has pioneered real-time, robust, label-free analysis for determination of affinity, kinetics, and analyte quantitation. Making the characterization of drug candidates significantly easier, faster and better! Octet®️ systems deliver greater value over traditional techniques with limited throughput, and performance. Discover the fastest and most flexible system on the market with an enviable range of applications.

The baculovirus-insect cell system is widely used for production of recombinant proteins and clinical stage AAV due to its flexibility, speed, simplicity, and productivity. With the Sf-RVN® Platform, we provide a rhabdovirus-free cell line that improves the safety profile of your bioprocesses combined with a chemically defined medium specifically formulated to get excellent growth and productivity while adhering to evolving regulatory requirements.